Bhagat Sarah M 4
4 · Inozyme Pharma, Inc. · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Bhagat Sarah M
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-23+9,367→ 9,367 totalExercise: $17.12Exp: 2031-06-22→ Common Stock (9,367 underlying)
Footnotes (1)
- [F1]The option was granted on June 23, 2021. The shares underlying the option are scheduled to vest as to 100% of the shares on June 23, 2022, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.